Federal recipient
Altimmune, Inc.
$0 committed in FY2025 — no awards to them that year.See all years →Jump to FY2024 →
- District
- MD-06
- Location
- 19 Firstfield RD Ste 200, Gaithersburg, MD, 20878
- UEI
- WPSTEWANH2Q8
- DUNS
- 032198363
- Also known as
- Vaxin Inc., Vaxin Pharmaceuticals Inc, Vaxin Pharmaceuticals, Inc
What they sell
Top products and services Altimmune, Inc. sells the government under contract, by dollars committed.
Health R&D Services; Health Care Services; Experimental Development
$29.9M
Drugs and Biologicals
$18.1M
Competition
How many of Altimmune, Inc.'s priced contract actions drew exactly one offer — a competition on paper with a single bidder. A high share doesn't prove anything improper; it's a flag worth a second look.
Single offer
8
80%
Multiple offers
2
20%
What budget it comes from
The Treasury accounts Altimmune, Inc.'s awards draw on. Dollars committed on awards that span more than one account are split evenly across them.
Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services
075-0140
$48.0M
2 awards
Committed by fiscal year
Dollars committed to Altimmune, Inc., per fiscal year (FY2018–FY2024).
How to read these numbers
- Committed to this recipient
The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.
- Lifetime vs. a single year
The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.
- “Active in FY X”
A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.
- Names come raw
Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.
- The colored bars
Every bar on this page splits by how the money moves:
Direct payments
